Embody vs altRx: Which GLP-1 Costs Less in 2026?
Embody is $69/mo semaglutide and $119 tirzepatide; altRx is $89 and $149 with prepay plans. Full 12-month cost comparison and who each suits.
Quick Verdict
Editorial Take
Best Overall: Embody, on price. It is cheaper than altRx on both molecules whether you pay monthly or compare against altRx multi-month prepay plans, and it does not ask you to commit upfront to get its best rate.
Best for Budget: Embody at $69/month for semaglutide, $828 over a year, against altRx at $89/month. Even altRx’s cheapest 12-month prepay rate of $75/month ($900 total) does not beat Embody’s month-to-month price.
Best for Fast Approval: Effectively tied. Both run fully online intake with licensed clinician review and ship in about 2 days after approval, Embody quoting 1–2 days and altRx 2 days.
At a Glance Comparison
| Feature | Embody | altRx |
|---|---|---|
| Semaglutide price | $69/month | $89/month |
| Tirzepatide price | $119/month | $149/month |
| Prepay discounts | None, one flat monthly rate | Yes, down to $75/mo semaglutide or $125/mo tirzepatide on 12 months |
| Commitment | None, cancel anytime | None, cancel anytime |
| Membership fees | None | None |
| Shipping | Free, 1–2 days | Free discreet 2-day delivery |
| Supplies included | Medication and support | Medication, sterile syringes and alcohol prep pads itemised |
| Clinical provider | Licensed telehealth clinician network | CareValidate Health, a network of U.S.-licensed doctors |
| Pay over time | Not advertised | Affirm, Klarna, Afterpay |
Who Should Choose Embody
Choose Embody if:
- ✓You want the lowest monthly price on either molecule without prepaying
- ✓You want to stay month-to-month and keep the option to stop after 30 days
- ✓You want tirzepatide as cheaply as possible, where the $30/month gap is widest in absolute terms
- ✓You do not need supplies itemised in advance and are comfortable confirming what ships during intake
Who Should Choose altRx
Choose altRx if:
- ✓You want to spread the cost with Affirm, Klarna or Afterpay, which Embody does not advertise
- ✓You prefer knowing the specific clinical group behind the prescription, named here as CareValidate Health
- ✓You want the injection supplies spelled out before you buy rather than confirmed at intake
- ✓You are confident you will stay on treatment a full year and prefer to lock the total cost upfront
Embody Deep Dive
Embody is a telehealth platform prescribing compounded semaglutide and tirzepatide through a fully online process, built around speed and a low flat price. Its semaglutide sits at $69/month, cut from a previous $299, which makes it one of the most aggressively priced compounded programmes in 2026.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and, if appropriate, prescribes
- Medication is compounded and ships free within 1–2 days of approval
- Continue month to month, cancel at any time without penalty
Medications Offered
- ✓Compounded semaglutide at $69/month
- ✓Compounded tirzepatide at $119/month
Pricing
One flat monthly rate per molecule with free shipping and 24/7 support included, no membership fee and no minimum term. Final pricing can vary slightly with your dose and clinician recommendation, so confirm the all-in figure at enrollment.
- ✓Cheapest of the two on both molecules, monthly or annualised
- ✓No prepayment required to reach its best price
- ✓Free 1–2 day shipping
- ✓No membership fee and no long-term contract
- ✗No multi-month discount, so there is no way to lower the rate further
- ✗No advertised buy-now-pay-later option
- ✗Does not name a single public pharmacy partner, so ask during intake
- ✗Compounded medication is not an FDA-approved finished product
altRx Deep Dive
altRx is a compounded GLP-1 telehealth provider whose clinical services are delivered by CareValidate Health, a network of U.S.-licensed doctors. It prices slightly above Embody but is more explicit about what the price covers and offers prepay plans plus instalment financing.
How It Works
- Take the short online eligibility quiz, free and with no commitment
- A licensed CareValidate Health clinician reviews your history and builds a dosing plan
- Your kit ships via free, discreet 2-day delivery once approved
- Choose month-to-month or a 3, 6 or 12-month plan at a lower rate
Medications Offered
- ✓Compounded semaglutide at $89/month, or $85/$80/$75 on 3, 6 and 12-month plans
- ✓Compounded tirzepatide at $149/month, or $144/$130/$125 on 3, 6 and 12-month plans
Pricing
Transparent tiered pricing with no membership, insurance or hidden fees. Every plan includes the online medical visit, the medication, sterile syringes, alcohol prep pads, dosing guidance, free 2-day delivery and care team support. Affirm, Klarna and Afterpay are available.
- ✓Named clinical provider, which not every compounded programme discloses
- ✓Supplies itemised rather than assumed
- ✓Prepay tiers and buy-now-pay-later for spreading cost
- ✓No membership or hidden fees, cancel anytime
- ✗More expensive than Embody on both molecules at every tier
- ✗Its best rates require paying 6 or 12 months upfront
- ✗Compounded medication is not an FDA-approved finished product
Honest Tradeoffs
Pricing
Embody is cheaper, and the prepay tiers do not change that. altRx at $75/month for semaglutide sounds lower than Embody’s $69 until you notice it requires $900 upfront for twelve months, against Embody’s $828 paid monthly with the freedom to stop. The gap is $20/month on semaglutide and $30/month on tirzepatide at the month-to-month rates.
Medication Types
Functionally identical. Both prescribe compounded semaglutide and compounded tirzepatide, neither of which is an FDA-approved finished product, though both use the same active ingredients as Ozempic, Wegovy, Mounjaro and Zepbound. There is no molecule available at one and not the other.
Doctor Involvement
altRx is more specific, naming CareValidate Health as the clinical group. Embody describes a licensed clinician network without naming it. Both require clinician review before dispensing and neither is a subscribe-and-ship product. Whether the named partner matters to you is a reasonable personal call.
Delivery Speed
Close enough not to decide it. Embody quotes 1–2 days after approval, altRx quotes 2-day discreet delivery, and both ship free. Real-world variance between the two will usually be smaller than the variance introduced by when your clinician review completes.
Subscription Model
Both are month-to-month with no membership fee and cancellation at any time. altRx adds optional prepay tiers and instalment financing; Embody keeps a single flat rate. If you want to spread payments rather than reduce them, altRx is the only one of the two offering it.
Pricing Breakdown
| Aspect | Embody | altRx |
|---|---|---|
| Semaglutide, monthly | $69 | $89 |
| Tirzepatide, monthly | $119 | $149 |
| Semaglutide, best rate | $69 (no prepay needed) | $75 (12 months prepaid, $900) |
| Tirzepatide, best rate | $119 (no prepay needed) | $125 (12 months prepaid, $1,500) |
| Membership fee | None | None |
| Financing | Not advertised | Affirm, Klarna, Afterpay |
What You Actually Pay Over 12 Months
Advertised starting prices are the least useful number in this comparison, so below is what each provider costs across a realistic course of treatment rather than on day one. Pricing verified July 30, 2026; confirm the final figure at enrollment, as offers change.
| Embody | altRx | |
|---|---|---|
| First month | $69 semaglutide / $119 tirzepatide | $89 semaglutide / $149 tirzepatide |
| 6-month total | $414 semaglutide / $714 tirzepatide | $480 semaglutide / $780 tirzepatide, on the prepaid 6-month plans |
| 12-month total | $828 semaglutide / $1,428 tirzepatide | $900 semaglutide / $1,500 tirzepatide, on the prepaid 12-month plans |
| Price includes | Medication, clinician review, free 1–2 day shipping and 24/7 support, with no membership fee | Medical visit, medication, sterile syringes, alcohol prep pads, free 2-day delivery and care team support |
| What can raise it | Final pricing can vary slightly with your prescribed dose, so confirm the all-in figure at enrollment | Reaching the lowest per-month rates requires paying 6 or 12 months upfront; month-to-month stays at $89/$149 |
The prepay tiers are what make this comparison look closer than it is. altRx advertises $75/month semaglutide, below Embody’s $69 headline in appearance only, because reaching it costs $900 for twelve months against Embody’s $828 paid month by month. On tirzepatide the same pattern is wider still: $1,500 prepaid at altRx against $1,428 at Embody with no commitment. Embody is cheaper at every comparable point and does not require you to buy a year to get there. altRx earns its premium on other terms, naming its clinical group, itemising the injection supplies and offering Affirm, Klarna and Afterpay, and those are legitimate reasons to pay $20–30 more a month. They are just not price reasons.
Medication Comparison
Semaglutide
Both offer compounded semaglutide, the active ingredient in Ozempic and Wegovy. Embody is $69/month, altRx is $89/month, a $240 difference over a year at the month-to-month rates.
Tirzepatide
Both offer compounded tirzepatide, the dual-agonist ingredient in Mounjaro and Zepbound. Embody is $119/month against altRx at $149/month, a $360 difference over a year. This is the wider gap of the two in absolute terms.
Which Provider Offers What
There is no medication exclusive to either provider. Both carry semaglutide and tirzepatide in compounded form, so the choice rests on price, payment structure and clinical disclosure rather than on which molecules you can access.
Results Expectations
Safety Considerations
Side Effects
Both carry the GLP-1 side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort are the common ones, usually dose-related and most pronounced during titration. Serious risks including pancreatitis and gallbladder disease are described in the FDA labelling for the branded products. Disclose your full medication list and history during intake.
Doctor Supervision
Both require review by a licensed U.S. clinician before any prescription is issued, and both provide ongoing care team access for dose adjustment. altRx names CareValidate Health as its clinical group; Embody describes a licensed clinician network without naming it publicly.
Prescription Requirement
Both are prescription-only and neither can be bought over the counter. Compounded semaglutide and tirzepatide are not FDA-approved finished products; they are prepared by compounding pharmacies using FDA-approved active ingredients, which is a meaningful distinction to understand before starting either.
How We Evaluated These Providers
We evaluated both providers based on the following criteria:
- ✓Published monthly pricing for each molecule, and the annualised total at every plan tier
- ✓What the quoted price actually includes, including whether injection supplies are itemised
- ✓Clinical disclosure: whether the prescribing group is publicly named
- ✓Commitment terms, cancellation and availability of instalment financing
- ✓Shipping speed and cost as quoted by each provider
Final Verdict
Editorial Take
Best for Budget Users
Embody, without much argument. It is $240/year cheaper on semaglutide and $360/year cheaper on tirzepatide, and it reaches those prices without asking for money upfront.
Best for Fast Results
Effectively tied, and neither can credibly claim faster results. Both ship in roughly two days after clinician approval and dispense the same molecules; speed of outcome depends on dose titration and adherence rather than on the platform.
Best for Doctor Supervision
altRx, marginally, for naming CareValidate Health as its clinical provider. Both require genuine clinician review, so this is about disclosure rather than a difference in the standard of oversight.
Best Premium Experience
altRx, if you define premium as itemised supplies, a named clinical partner and the option to spread payments. If you define it as the lowest price with the fewest strings, Embody takes it.
Frequently Asked Questions
Read Our Full Reviews
Related Comparisons
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.